These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 664993)

  • 1. Immunological barrier of the central nervous system in neurosurgical diseases.
    Mrówka R; Kósmiderski S
    Zentralbl Neurochir; 1978; 39(1):85-90. PubMed ID: 664993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunological barrier of the central nervous system in neurosurgical diseases].
    Mrówka R; Kośmiderski S; Wencel T
    Wiad Lek; 1976 Oct; 29(20):1807-11. PubMed ID: 997503
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes with age in leucocyte counts, protein and IgG content of lumbar cerebrospinal fluid (CSF) of patients with inflammatory, ischemic, and hemorrhagic diseases or tumors of the central nervous system (CNS).
    Kleine TO; Weber L; Zöfel P
    Z Gerontol; 1988; 21(2):102-5. PubMed ID: 3381557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Crystallographic method of studying the cerebrospinal fluid in diseases of the central nervous system].
    Neretin WJ; Kirjakov WA
    Psychiatr Neurol Med Psychol (Leipz); 1977 Aug; 29(8):474-81. PubMed ID: 928566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.
    Zylber-Katz E; Gomori JM; Schwartz A; Lossos A; Bokstein F; Siegal T
    Clin Pharmacol Ther; 2000 Jun; 67(6):631-41. PubMed ID: 10872645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Herpes simplex and lymphocytic choriomeningitis viruses in infections of the central nervous system--clinical and cerebrospinal fluid characteristics].
    Turkulov V; Madle-Samardzija N; Ilić A; Vukadinov J; Canak G
    Med Pregl; 1998; 51(9-10):436-40. PubMed ID: 9863335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Specific and nonspecific therapy of virus diseases of the central nervous system].
    Neu IS; Günther W
    Nervenarzt; 1984 Feb; 55(2):57-61. PubMed ID: 6700802
    [No Abstract]   [Full Text] [Related]  

  • 8. [Brain tumors with acute or apoplectiform initial symptoms].
    Klein M; Mertsch H
    Psychiatr Neurol Med Psychol (Leipz); 1981 Dec; 33(12):718-25. PubMed ID: 7335826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The permeability of the blood-cerebrospinal fluid barrier in the first 24 hours after cranio-cerebral injury].
    Moshkin AV
    Lab Delo; 1990; (10):47-50. PubMed ID: 1704459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trauma to the central nervous system.
    Gildenberg PL; Wycis HT
    Prog Neurol Psychiatry; 1970; 25():302-11. PubMed ID: 4922509
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immune status dynamics in different lateralizations of focal traumatic brain lesions].
    Gorbunov VI; Gannushkina IV; Likhterman LB
    Zh Vopr Neirokhir Im N N Burdenko; 1994; (3):13-6. PubMed ID: 7985436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. II. The "blood-brain barrier" its pathology and its importance in anesthesia.
    Dal Santo G
    Clin Anesth; 1967; 3():17-57. PubMed ID: 5584317
    [No Abstract]   [Full Text] [Related]  

  • 13. [Method and clinical significance of cerebrospinal fluid spectrophotometry].
    Müller FA; Farago F; Kaufmann H; Bürgi W
    Nervenarzt; 1989 May; 60(5):255-61. PubMed ID: 2739818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transport and production of cerebrospinal fluid (CSF) change in aging humans under normal and diseased conditions.
    Kleine TO; Hackler R; Lütcke A; Dauch W; Zöfel P
    Z Gerontol; 1993; 26(4):251-5. PubMed ID: 8212795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Beta 2-microglobulin and tumors of the central nervous system].
    Hrazdirová V; Hrazdira CL; Polcáková M
    Cesk Neurol Neurochir; 1990 Jan; 53(1):17-21. PubMed ID: 2185897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systemic and regional neuroimmune processes in focal CNS lesions].
    Lisianyĭ NI; Rudenko VA; Markova OV; Gnedkova IA; Lisianaia TA; Liubich LD; Gorobets OB; Bel'skaia LN
    Fiziol Cheloveka; 2000; 26(1):92-9. PubMed ID: 10752297
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lyme borreliosis: significance of the serological diagnosis of an infection with Borrelia burgdorferi in neurological diseases with inflammatory cerebrospinal fluid syndrome].
    Hug H; Altpeter ES; Mumenthaler M; Meier C
    Schweiz Med Wochenschr; 1992 Jul; 122(27-28):1029-36. PubMed ID: 1321489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-brain antibodies in serum and cerebrospinal fluid following cranio-cerebral trauma].
    Detlav IE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(3):344-8. PubMed ID: 1266503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoembryonic antigen in patients with untreated central nervous system tumors.
    Kido DK; Dyce BJ; Haverback BJ; Rumbaugh CL
    Bull Los Angeles Neurol Soc; 1976 Apr; 41(2):47-54. PubMed ID: 1030651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [IgG synthesis in the central nervous system in multiple sclerosis and other neurologic diseases. Measurement and validity].
    Safár J; Vymazal J; Tichý J; Růzicková V
    Cas Lek Cesk; 1985 Sep; 124(36):1131-6. PubMed ID: 4028102
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.